Prof. Dr. Frank Lampe: Alternative cancer therapy with cancer enzyme capsules

 
Analyzes at Japanese research institutes have shown that there is now good progress in the treatment of one of the world's deadliest diseases.
The Japanese National Cancer Center has found that since 2012, when it began evaluating the data from these analyzes from more than 350 medical institutions, there has been a trend towards improving cancer patient survival rates.
 
After cardiovascular diseases, cancer is the second cause of death worldwide. Affected patients are increasingly asking about alternatives or additions to conventional medicine. Alternative cancer therapy provides the answers. Here, Prof. Dr. Lampe suggests the possibility of alternative cancer therapy with enzymes, tailored to the special type of cancer.
 
Each development of cancer is individual and should be adapted to the type of cancer.
There are aggressive tumors, slow growing tumors, very fast growing tumors, highly aggressive tumors and tumors that quickly metastasize.
 
The healing of the disease depends on the beginning and the type of therapy as well as the inner attitude of the person concerned.
 
The usual academic medical therapy for cancer often consists of surgery, radiation therapy, chemotherapy.
 
These treatments are often used in combination.
The known side effects of radiation and chemotherapy particularly affect rapidly dividing cells. These are primarily cancer cells, of course, but unfortunately also cells of the intestinal mucosa as well as red and white blood cells and platelets.

Cancer enzymes

Cancer survival rates are increased when taking cancer enzyme capsules.
Analyzes at Japanese research institutes have shown that there is now good progress in the treatment of one of the deadliest diseases in the world.
The Japanese National Cancer Center has found that since 2012, when it began evaluating the data of these analyzes from more than 350 medical institutions, there has been a trend towards improving cancer patient survival rates.
In Japan, among the eight most common cancers there, women with breast cancer have the highest survival rate at 92.6 percent. Followed by colorectal cancer patients with a 73.4 percent survival rate, followed by stomach cancer with 71.8 percent, liver cancer with 68.5 percent
and lung and trachea cancer at 41.4 percent.
Of larynx cancer patients, around 90 percent are male. However, there is an 80.7 percent chance of survival. In kidney cancer, survival rate is still at 80.3 percent, whereas in cancer of the renal pelvis or ureter it is just 51.3 percent.

 

Our advice

Blood cancer enzyme Prof. Dr. Frank Lampe
TOP
Made in Japan
73,85 EUR
Non-Hodgkin lymphoma enzyme Prof. Dr. Frank Lampe
TOP
79,60 EUR
Breast cancer enzyme
TOP

Made in Japan M.H.D. 18 Monate

72,90 EUR
Germanium sesquioxide GE-132: Manufactured Prof. Dr. Frank Lampe
TOP
Made in Japan M.H.D. 30 Monate
from 26,50 EUR
Bladder cancer enzyme
TOP
Made in Japan
73,20 EUR
Kidney cancer enzyme Prof. Dr. Frank Lampe
TOP
73,50 EUR
Germanium capsules: Manufactured according to Dr. Kazuhiko Asai with 440 mg. GE-132 per capsule
TOP
Made in Japan M.H.D. 20 Monate
from 79,99 EUR
Cervical cancer enzyme
TOP
73,10 EUR
Larynx cancer enzyme Prof. Dr. Frank Lampe
TOP
Made in Japan
73,45 EUR
TOP
from 317,95 EUR